The antiemetic prophylaxis for the PONV (postoperative nausea and vomiting) in patients undergoing microvascular decompression: a prospective randomized controlled trial

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2020
INTERVENTION: Intervention: Ramosetron (0.3 mg) is administered at the end of surgery Control: Normal saline 1cc is administered at the end of surgery CONDITION: Healthy adults PRIMARY OUTCOME: The incidence of postoperative nausea and vomiting (PONV) at postoperative 48 hours SECONDARY OUTCOME: The severity of PONV; antiemetics requirements; PCA consumption; Length of hospital stay INCLUSION CRITERIA:
Epistemonikos ID: 4a8e01bb23aa023fef30d58d1973730dcd7c62c7
First added on: Aug 24, 2024